Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2426
4D Molecular Therapeutics
FDMT
$692M
| $2.57M | ﹤0.01% |
179,867
+156,042
| +655% | +$2.03M |
2022 Q1
18 quarters
|
|
2427
Microchip Technology Inc 7.50% Series A Preferred Stock
MCHPP
| $2.57M | ﹤0.01% |
38,537
+10,675
| +38% | +$714K |
2025 Q1
6 quarters
|
|
2428
Center Bancorp
CNOB
$1.65B
| $2.56M | ﹤0.01% |
85,270
+17,070
| +25% | +$550K |
2016 Q2
41 quarters
|
|
2429
CareDx
CDNA
$4.1B
| $2.55M | ﹤0.01% |
39,197
+31,221
| +391% | +$1.41M |
2017 Q4
35 quarters
|
|
2430
Everforth Inc
EFOR
$1.46B
| $2.53M | ﹤0.01% |
76,920
+69,897
| +995% | +$1.95M |
2016 Q3
40 quarters
|
|
2431
CoreCivic
CXW
$2.78B
| $2.53M | ﹤0.01% |
78,391
+50,263
| +179% | +$1.63M |
2013 Q2
53 quarters
|
|
2432
Hornbeck Offshore Services, Inc.
HOS
$1.31B
| $2.51M | ﹤0.01% |
326,884
+151,822
| +87% | +$1.42M |
2013 Q2
53 quarters
|
|
2433
ArriVent BioPharma
AVBP
$677M
| $2.5M | ﹤0.01% |
82,452
+11,482
| +16% | +$352K |
2024 Q1
10 quarters
|
|
2434
Frontdoor
FTDR
$6.64B
| $2.5M | ﹤0.01% |
34,134
+12,273
| +56% | +$965K |
2018 Q4
31 quarters
|
|
2435
Radian Group
RDN
$4.7B
| $2.49M | ﹤0.01% |
81,373
+33,673
| +71% | +$1.24M |
2013 Q2
53 quarters
|
|
2436
CALL
Biogen
BIIB
$37.3B
| $2.48M | ﹤0.01% |
+11,000
| New | +$2.33M |
2026 Q3
0 quarters
|
|
2437
CALL
Arista Networks
ANET
$252B
| $2.48M | ﹤0.01% |
+12,200
| New | +$2.3M |
2026 Q3
0 quarters
|
|
2438
EverQuote
EVER
$1.04B
| $2.48M | ﹤0.01% |
123,624
+118,777
| +2,451% | +$2.89M |
2019 Q1
30 quarters
|
|
2439
IDEAYA Biosciences
IDYA
$3.09B
| $2.48M | ﹤0.01% |
64,434
+48,150
| +296% | +$1.82M |
2020 Q2
25 quarters
|
|
2440
Unifirst Corp
UNF
$4.37B
| $2.47M | ﹤0.01% |
9,879
+1,183
| +14% | +$331K |
2013 Q2
53 quarters
|
|
2441
Edgewise Therapeutics
EWTX
$5.07B
| $2.47M | ﹤0.01% |
60,887
-129,318
| -68% | -$5.5M |
2022 Q1
18 quarters
|
|
2442
USA Rare Earth Inc
USAR
$3.15B
| $2.47M | ﹤0.01% |
175,131
+142,906
| +443% | +$2.43M |
2025 Q3
4 quarters
|
|
2443
EquipmentShare.com Inc
EQPT
$4.02B
| $2.46M | ﹤0.01% |
141,350
+137,376
| +3,457% | +$2.54M |
2026 Q1
2 quarters
|
|
2444
Zillow
ZG
$6.72B
| $2.46M | ﹤0.01% |
88,631
+30,299
| +52% | +$1.01M |
2013 Q2
53 quarters
|
|
2445
PUT
Alignment Healthcare
ALHC
$1.59B
| $2.45M | ﹤0.01% |
+300,100
| New | +$4.48M |
2026 Q3
0 quarters
|
|
2446
PUT
Colgate-Palmolive
CL
$78.5B
| $2.45M | ﹤0.01% |
+28,700
| New | +$2.6M |
2026 Q3
0 quarters
|
|
2447
Hertz
HTZ
$554M
| $2.45M | ﹤0.01% |
1,464,487
+478,519
| +49% | +$952K |
2022 Q1
18 quarters
|
|
2448
Academy Sports + Outdoors
ASO
$4.2B
| $2.45M | ﹤0.01% |
50,843
+26,141
| +106% | +$1.24M |
2022 Q1
18 quarters
|
|
2449
Haleon
HLN
$40.3B
| $2.44M | ﹤0.01% |
271,664
-141,124
| -34% | -$1.37M |
2025 Q3
4 quarters
|
|
2450
iShares Ethereum Trust ETF
ETHA
$6.02B
| $2.44M | ﹤0.01% |
40,495
-11,611
| -22% | -$569K |
2025 Q3
4 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.